Susquehanna International Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Susquehanna International Group’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-133,400	Closed	-$1.22M	–	14067
2021 Q2	$1.22M	Buy	133,400 +55,000	+70%	+$320K	﹤0.01%	7187
2021 Q1	$390K	Buy	+78,400	New	+$379K	﹤0.01%	10041
2020 Q4	–	Sell	-18,700	Closed	-$80K	–	11999
2020 Q3	$80K	Sell	18,700 -9,000	-32%	-$37.6K	﹤0.01%	10039
2020 Q2	$124K	Buy	+27,700	New	+$124K	﹤0.01%	9389
2019 Q3	–	Sell	-13,100	Closed	-$109K	–	11105
2019 Q2	$109K	Buy	+13,100	New	+$113K	﹤0.01%	9569
2018 Q4	–	Sell	-18,100	Closed	-$252K	–	10358
2018 Q3	$252K	Buy	+18,100	New	+$245K	﹤0.01%	7809

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group's KIN Position: Q3 2021 in Review

Susquehanna International Group sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 54,003 shares — an estimated $495K sold.

Susquehanna International Group first reported a position in KIN in Q2 2015 and held it in 16 quarters. The position peaked at $612K in Q2 2015. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Susquehanna International Group reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Susquehanna International Group sold 54,003 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $495K.
Susquehanna International Group first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 16 quarters.
Susquehanna International Group's Kindred Biosciences, Inc. position peaked at $612K in Q2 2015.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.